- Home
- » Tags
- » Tigecycline
Top View
- UK-VARSS 2018 Supplementary Material
- The Efficacy and Safety of Tigecycline for the Treatment of Complicated
- Tigecycline and Comparator Activity Against S. Agalactiae Collected from the TEST Program (2010-2012) 2122 Palmer Dr
- Recommendations for Anti-Microbial Use for Secondary Infections in Patients with COVID-19 Rapid Review
- Tygacil® (Tigecycline) for Injection
- Tigecycline-Amikacin Combination Effectively Suppresses the Selection of Resistance in Clinical Isolates of KPC-Producing Klebsiella Pneumoniae
- TYGACIL (Tigecycline) Is a Tetracycline Derivative (A Glycylcycline) for Intravenous Infusion
- Tigecycline (Tygacil®) (Tygacil®)
- Antibiotic Considerations in the Treatment of Multidrug-Resistant (MDR) Pathogens: a Case-Based Review
- Clinical Efficacy and Adverse Effects of Antibiotics Used to Treat
- ANTIBIOTIC RESISTANCE THREATS in the United States, 2013
- Treatment of Mycobacterium Abscessus Infection
- Synergistic Antibacterial Effect of Casein-Agnps Combined with Tigecycline Against Acinetobacter Baumannii
- Controlled Release of Vancomycin and Tigecycline from an Orthopaedic Implant Coating Prevents Staphylococcus Aureus Infection in an Open Fracture Animal Model
- Tigecycline Exhibits Inhibitory Activity Against Clostridium Difficile in The
- Drug Resistance Updates 40 (2018) 25–39
- Doxycycline and Tigecycline: Two Friendly Drugs with a Low Association with Clostridium Difficile Infection
- Supplementary Material UK-VARSS 2019
- TYGACIL (Tigecycline) Is a Tetracycline Derivative (A Glycylcycline) for Intravenous Infusion
- Double Anaerobic Coverage: What Is the Role in Clinical Practice?
- List Item ECDC, EFSA and EMA Joint Scientific Opinion on a List of Outcome Indicators As
- Tigecycline : First Member of the Novel Glycylcycline Class of Extended-Spectrum Antibiotics
- Antibiotic Consumption and Healthcare-Associated Infections in a Tertiary Hospital in Belgrade, Serbia from 2011 to 2016
- Osteomyelitis: an Overview of Antimicrobial Therapy
- INTEGRATED SURVEILLANCE of ANTIMICROBIAL RESISTANCE in FOODBORNE BACTERIA Application of a One Health Approach
- Tigecycline, in Vitro Studies
- COMPARISON of the WHO ATC CLASSIFICATION & Ephmra/PBIRG ANATOMICAL CLASSIFICATION
- Clinical Pharmacology & Biopharmaceutics Review
- Structural Basis for Potent Inhibitory Activity of the Antibiotic Tigecycline During Protein Synthesis
- The Synergistic Activity and Optimizing Doses of Tigecycline in Combination with Aminoglycosides Against Clinical Carbapenem-Resistant Klebsiella Pneumoniae Isolates
- Gram-Positive Recs for Use Ceftaroline, Daptomycin, Linezolid
- Appropriate Use of Tetracyclines
- Package Leaflet: Information for the User Tigecycline 50 Mg Powder For
- Comparison of Antibiotic Resistance Mechanisms in Antibiotic-Producing and Pathogenic Bacteria
- In Vitro Activity of Biofilm Inhibitors in Combination with Antibacterial Drugs Against Extensively Drug-Resistant Acinetobacter
- Tigecycline Induction of Phenol-Soluble Modulins by Invasive Methicillin-Resistant Staphylococcus Aureus Strains Jason Yamaki Chapman University, [email protected]
- Tetracycline Allergy
- Norm Norm-Vet 2015
- The Third-Generation Tetracycline KBP-7072 Exploits and Reveals a New Potential of the Primary Tetracycline Binding Pocket
- NORM Normgvet
- Tygacil, INN-Tigecycline
- Norm Norm-Vet 2016
- In-Vitro Efficacy of Imipenem with Tigecycline and Amikacin Against Extensively Drug Resistant Acinetobacter Baumannii
- M. ABSCESSUS: UPDATE on MANAGEMENT Doreen J
- Quantitative Assessment of the Combination of Doripenem Or
- Life Antibiotic Use, Asthma and Eczema
- Linezolid- and Vancomycin-Resistant Enterococcus Faecium Endocarditis: Successful Treatment with Tigecycline and Daptomycin
- Is There an Optimal Regimen for the Treatment of MDR and XDR Infection?
- Efficacy of Minocycline and Tigecycline in a Hamster Model of Leptospirosis☆,☆☆ Charla C
- Supplements Supplement 1
- Evolution and Mechanisms of Tigecycline Resistance in Escherichia Coli